ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyAllschwilIlonov Therapeutics SA
Ilonov Therapeutics SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Ilonov Therapeutics SA is a preclinical-stage biopharmaceutical company developing biotherapies for diabetes and metabolic diseases. Its research uses myokines from the muscle secretome, with development programs addressing type 1 and type 2 diabetes.

AI-generated
Presence

Service area

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.7/5

Ilonov Therapeutics SA

Offering

Products & services

Industry:Pharmaceutical company
✓ Offered4
Development of biotherapies against diabetes
Biopharmaceutical development of first-in-class biotherapies for diabetes and metabolic diseases based on the muscle secretome and newly discovered targets.
Therapeutic candidate ILV-001 for type 1 diabetes
ILV-001-based pre- and post-transplant treatment to improve islet survival, limit rejection and support beta-cell replacement therapies.
Therapeutic candidate ILV-001 for type 2 diabetes
Biotherapy to slow the progression of type 2 diabetes, with restoration of insulin sensitivity in peripheral tissues and protection of insulin-secreting cells.
Research on the muscle secretome and myokines
Basic and translational research on the muscle secretome, on myokines and on muscle-pancreas signaling as a therapeutic foundation.
Trust & reputation

ranQ Trust Score of Ilonov Therapeutics SA: 3.7 out of 5.0

Trust Score3.7/ 5.0

Solid

x

Data basis 54% · As of November 2026

Ilonov Therapeutics SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Ilonov Therapeutics SA scores 53.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Ilonov Therapeutics SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Ilonov Therapeutics SA scores 8.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.8.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Ilonov Therapeutics SA reaches a ranQ Trust Score of 3.7 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Ilonov Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Ilonov Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Ilonov Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Ilonov Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hegenheimermattweg 167a
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-145.522.755
Founded
2025 · 1 year
Last commercial register change
September 8, 2026
Employees
1 to 10

Active in 1 of 26 cantons

Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology
    BLBasel-Country

    Similar companies

    MG
    MiHKAL GmbH
    Allschwil
    NS
    Neurocrine Switzerland GmbH
    Allschwil
    IL
    Idorsia Ltd
    Allschwil
    AS
    AlphaMol Science AG
    Allschwil
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil
    BW
    Blue Wave Therapeutics GmbH
    Allschwil
    MP
    Merz Pharma (Schweiz) AG
    Allschwil
    PT
    Palto Therapeutics AG
    Allschwil